MindSense

Company Overview

Snapshot

Founded in January 2021 by Shlomo Mendlovic and Mor Bar, MindSense operates with 1–10 employees. The company secured one disclosed funding round and ceased operations in January 2022.

Business overview

MindSense is a deep-technology psychotherapy company that leverages AI to provide omni-channel insights for therapy sessions. Its core technology decodes therapy interactions into measurable data points, enabling therapists to track outcomes and manage treatment effectively. The platform utilizes proprietary AI to translate statements into data, summarizing sessions with objective, personalized guidance and counseling feedback. MindSense operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support, serving healthcare providers in markets such as North America, Denmark, Germany, and the United Kingdom.

Strategic signal

MindSense ceased operations in January 2022, less than a year after its founding. This indicates a rapid conclusion to the company's venture into AI-based psychotherapy assistance, suggesting challenges in market adoption, funding, or operational viability despite its innovative approach to mental health technology.

Company Intelligence Q&A

What is MindSense's primary focus?

MindSense focuses on developing an AI-based psychotherapy assistance platform that provides measurable insights from therapy sessions to help therapists improve treatment outcomes and deliver better care.

When was MindSense founded?

MindSense was founded in January 2021.

What is the operational status of MindSense?

MindSense ceased to operate in January 2022.

What technology does MindSense utilize?

MindSense utilizes proprietary AI technology, including machine learning and natural language processing, to analyze therapy sessions and provide actionable insights.

Which markets did MindSense target?

MindSense targeted geomarkets including North America, Denmark, Germany, and the United Kingdom.